Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Invested Capital: 2010-2018

Historic Return on Invested Capital for China Pharma Holdings (CPHI) over the last 1 years, with Dec 2018 value amounting to -0.29%.

  • China Pharma Holdings' Return on Invested Capital was N/A to -0.29% in Q4 2018 from the same period last year, while for Dec 2018 it was -0.29%, marking a year-over-year change of. This contributed to the annual value of -0.27% for FY2018, which is N/A change from last year.
  • China Pharma Holdings' Return on Invested Capital amounted to -0.29% in Q4 2018, which was up 28.65% from -0.41% recorded in Q3 2018.
  • In the past 5 years, China Pharma Holdings' Return on Invested Capital ranged from a high of -0.07% in Q4 2015 and a low of -0.44% during Q1 2015.
  • In the last 2 years, China Pharma Holdings' Return on Invested Capital had a median value of -0.29% in 2018 and averaged -0.26%.
  • Over the last 5 years, China Pharma Holdings' Return on Invested Capital had its largest YoY gain of 30bps in 2015, and its largest YoY loss of 31bps in 2015.
  • China Pharma Holdings' Return on Invested Capital (Quarterly) stood at -0.37% in 2014, then increased by 30bps to -0.07% in 2015, then increased by 25bps to -0.09% in 2016, then reached -0.29% in 2018.
  • Its Return on Invested Capital stands at -0.29% for Q4 2018, versus -0.41% for Q3 2018 and -0.09% for Q2 2016.